SEC EDGAR Filing Information

Form 10-K -- Annual report [Section 13 and 15(d), not S-K Item 405]

Period of Report: 2008-12-31
Filing Date Changed: 2009-03-30
Documents: 9
SEC Accession No.
0000812796-09-000018
Filing date: 2009-03-30
Accepted: 2009-03-30 16:50:16

Table of submitted documents:

Seq Type Document Size Description
1 10-K dor10k2008.htm 1414108 DOR 10 K FOR 2008
2 EX-10.30 schaberempagree.htm 58884 DR. SCHABER EMPLOYMENT AGREEMENT
3 EX-10.31 myrianthopoulosempagree.htm 57731 MR. MYRIANTHOPOULOS EMPLOYMENT AGREEMENT
4 EX-10.32 clavijoempagree.htm 59160 MR. CLAVIJO EMPLOYEE AGREEMENT
5 EX-21.1 subsidiaries.htm 5281 SUBSIDIARIES
6 EX-31.1 ceocert.htm 12623 CEO CERTIFICATION
7 EX-31.2 cfocert.htm 12337 CFO CERTIFICATION
8 EX-32.1 ceosox906.htm 7385 CEO SOX 906 CERTIFICATION
9 EX-32.2 cfosox906.htm 6819 CFO SOX 906 CERTIFICATION
0000812796-09-000018.txt 1635953 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16929 | Film No.: 09714714
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
29 EMMONS DRIVE
SUITE C-10
PRINCETON NJ 08540
609-452-0001
 Mailing Address
29 EMMONS DRIVE
SUITE C-10
PRINCETON NJ 08540